RecruitingHIV Infection
Very Early Intensive Treatment of Infants Living With HIV to Achieve HIV Remission
Eligible age
All ages
Accepts
All genders
Locations
12 states
Healthy volunteers
No
See if you qualify for this study
Answer a few quick questions about your location and health. Takes about a minute.
About this study
The study will explore the effects of early intensive antiretroviral therapy (ART) with or without a broadly neutralizing antibody (bNAb) on achieving HIV remission (HIV RNA below the limit of detection of the assay) among infants living with HIV.
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Where it's recruiting
California
La Jolla · Los Angeles
Colorado
Aurora
Florida
Fort Lauderdale · Jacksonville · Miami
Georgia
Atlanta
Illinois
Chicago
Maryland
Baltimore
Massachusetts
Boston
New York
Stony Brook · The Bronx
Pennsylvania
Philadelphia
Tennessee
Memphis
Texas
Houston
Washington
Seattle
Source: ClinicalTrials.gov · NCT02140255 · last updated 2026-09-09